Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Blast phenotype and comutations in acute myeloid leukemia with mutated NPM1 influence disease biology and outcome.

Blood advances - 12 Nov 2019

Mason Emily F, Hasserjian Robert P, Aggarwal Nidhi, Seegmiller Adam C, Pozdnyakova Olga

Abstract excerpt

Recent work has identified distinct molecular subgroups of acute myeloid leukemia (AML) with implications for disease classification and prognosis. AML with mutated NPM1 (AML-NPM1) represents a distinct entity in the revised 2017 World Health Organization classification, but relatively little work has examined the clinical significance of phenotypic and genetic heterogeneity within this group. A...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Bone Marrow
Share to Follow-Up Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunophenotyping

Share to Kaplan-Meier Estimate

Share to Leukemia, Myeloid, Acute

Share to Nuclear Proteins

Share to Nucleophosmin

Source

Open in PubMed Open full text

Identifiers

PMID: 31698462
DOI: 10.1182/bloodadvances.2019000328
PMCID: PMC6855116

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Blast phenotype and comutations in acute myeloid leukemia with mutated NPM1 influence disease biology and outcome.PMID 31698462Read ↗

A distinct immunophenotype identifies a subset of NPM1-mutated AML with TET2 or IDH1/2 mutations and improved outcome.Semantic proximity Read ↗

Overlapping features of therapy-related and de novo NPM1-mutated AML.Semantic proximity Read ↗

Acute myeloid leukemia with mutated NPM1 mimics acute promyelocytic leukemia presentation.Semantic proximity Read ↗

Biological and clinical consequences of NPM1 mutations in AML.Semantic proximity Read ↗

Subtype-specific patterns of molecular mutations in acute myeloid leukemia.Semantic proximity Read ↗

Molecular Mutations and Their Cooccurrences in Cytogenetically Normal Acute Myeloid LeukemiaSemantic proximity Read ↗

Genomic Classification and Prognosis in Acute Myeloid Leukemia.Semantic proximity Read ↗

High NPM1-mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AML.Semantic proximity Read ↗

The NPM1 mutant defines AML irrespective of blast countSemantic proximity Read ↗

NPM1-mutated acute myeloid leukemia of monocytic or myeloid origin exhibit distinct immunophenotypes.Semantic proximity Read ↗

Cytogenetic abnormalities in NPM1-mutated acute myeloid leukemia.Semantic proximity Read ↗

Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.